Hematologic Toxicity

Hematologic Toxicity is a clinical adverse effect characterized by the suppression of bone marrow function, manifesting as a reduction in the production of circulating blood cells, particularly leukocytes, erythrocytes, and platelets, consequent to exposure to therapeutic radionuclides.

6.9K

Publications

314K

Citations

31.6K

Authors

5.1K

Institutions

Publications per year

2017–2026

843

Authors

31.6K

  1. HM
    Hagop M. Kantarjian

    The University of Texas MD Anderson Cancer Center, United States

    75 publications · 7.8K citations

    40

    h-index

  2. JE
    Jörge E. Cortes

    The University of Texas MD Anderson Cancer Center, United States

    47 publications · 6.3K citations

    31

    h-index

  3. GG
    Guillermo Garcia‐Manero

    The University of Texas MD Anderson Cancer Center, United States

    38 publications · 2.8K citations

    24

    h-index

  4. MT
    Moshe Talpaz

    The University of Texas MD Anderson Cancer Center, United States

    33 publications · 3.2K citations

    24

    h-index

  5. PF
    Pierre Fenaux

    Hôpital Saint-Louis, France

    31 publications · 2.6K citations

    23

    h-index

1–5 of 31.6K

Venues

  1. Blood

    295 publications · 26.5K citations

    92

    h-index

  2. Journal of Clinical Oncology

    199 publications · 25K citations

    84

    h-index

  3. PubMed

    Repository · 917 publications · 33.7K citations

    77

    h-index

  4. British Journal of Haematology

    BJH · 178 publications · 10.2K citations

    58

    h-index

  5. Cancer

    166 publications · 9.4K citations

    58

    h-index

1–5